Norbert Kraut
@norbertkraut1
Global Head of Cancer Research @Boehringer. Driven by the purpose of advancing science for healthier lives.
ID: 2984663866
18-01-2015 20:45:44
527 Tweet
920 Followers
530 Following
Out now in Nature Cancer. Our brand-new paper shows co-targeting of KRASG12C plus SOS1 as strategy for treating KRAS-G12C inhibitor-naïve and relapsed mutant tumors. Thanks to MD Anderson Cancer Center, Tim Heffernan and team and congrats to the Boehringer Ingelheim #KRAS team nature.com/articles/s4301…